News

Eli Lilly has ended a major COVID-19 antibody test among hospitalized patients

Pharmaceutical company Eli Lilly announced Monday it would stop trials testing an antibody drug in hospitalized patients after data suggested treatment was “unlikely” to help this group recover from COVID-19. Eli Lilly had paused trials of the treatment in mid October after an independent board of experts raised health concerns. […]
Eli Lilly has ended a major COVID-19 antibody test among hospitalized patients
News

Trump’s doctors say the president is getting better. But they also started him on a steroid usually reserved for patients with ‘severe and critical COVID-19’

White House physician Sean Conley announced Sunday that President Trump was feeling better. Conley said he hoped the president could return to the White House by Monday. But Trump’s doctors have chosen to give him dexamethasone, a corticosteroid, after the president required supplemental oxygen on Friday and Saturday. According to […]
Trump’s doctors say the president is getting better. But they also started him on a steroid usually reserved for patients with ‘severe and critical COVID-19’
News

The 10 most promising coronavirus treatments that could help curb the pandemic, even without a vaccine

Hundreds of experimental COVID-19 treatments have entered clinical testing in the last few months. Two – remdesivir and convalescent plasma – have gotten emergency authorization from the FDA. Here are the 10 candidates the scientific community finds most promising, including antibody therapeutics, plasma, and interferon drugs. Visit Business Insider’s homepage […]
The 10 most promising coronavirus treatments that could help curb the pandemic, even without a vaccine
Markets

Moderna is poised to surge another 45% in the next year, COVID-19 vaccine could generate more than $5 billion in annual sales, Jefferies says

On Monday, Jefferies initiated coverage of Moderna with a “buy” rating and a price target of $US90 on the potential that the pharmaceutical company’s COVID-19 vaccine is approved. That represents 45% upside from where shares of Moderna closed on Friday. Jefferies also thinks that if the COVID-19 vaccine is approved, […]
Moderna is poised to surge another 45% in the next year, COVID-19 vaccine could generate more than $5 billion in annual sales, Jefferies says